Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 172 |
| Receivables | 0 | N/A | 0 | 0 | 387 |
| Other current assets | 0 | 0 | 0 | 0 | 151 |
| TOTAL | $0 | $N/A | $0 | $0 | $710 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1,350 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 430 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,780 |
| Total Assets | $0 | $N/A | $0 | $0 | $2,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 160 |
| Accrued Expenses | 0 | N/A | 0 | 0 | 130 |
| Other current liabilities | 0 | N/A | 0 | 0 | 130 |
| TOTAL | $0 | $N/A | $0 | $0 | $436 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $N/A | $0 | $0 | $436 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 12,000 |
| Retained earnings | 0 | N/A | 0 | 0 | -10,316 |
| TOTAL | $0 | $N/A | $0 | $0 | $1,684 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $2,120 |